Pharmaceutical giant Purdue Pharma secretly pursued a plan to become "an end-to-end pain provider" by selling both opioids and drugs to treat opioid addiction, all while owners on the board reaped more than $4 billion in profits, alleges a new lawsuit. https://cnn.it/2Tspiar